Drug Chatter -- Tracking biopharma stock chatter

Profile for Spark Therapeutics, Inc. (ONCE)

« Back to company index

ONCE Chatter Timeline

Stock Ticker for ONCE

Most Active Tweeters for ONCE

UserTweets
@WatchlistN 8
@intercooleronli 8
@dailypoliticaln 7
@TheMarketsDaily 6
@WKRBNews 6

Recent Tweets for ONCE

CNBCTradersFan @CNBCTradersFan
RT SeekingAlpha "Spark Therapeutics: Let The PDUFA Run-Up Commence https://t.co/hrNEz2vwiB $QURE $ONCE"
12:07am
SeekingAlpha @SeekingAlpha
Spark Therapeutics: Let The PDUFA Run-Up Commence https://t.co/kQpA5StdFT $QURE $ONCE
12:07am
SleekMoneycom @SleekMoneycom
Spark Therapeutics, Inc. $ONCE Receives $73.83 Average Target Price from Analysts https://t.co/OO8vbOWjvW
12:07am
SPNewsAnalysis @SPNewsAnalysis
Spark Therapeutics, Inc. $ONCE Receives Average Rating of “Buy” from Analysts https://t.co/w9EW2kahxk
12:07am
storminvestor @storminvestor
Spark Therapeutics, Inc. $ONCE Receives Average Rating of “Buy” from Analysts https://t.co/f6HVdhGsKO
12:07am
TranscriptDaily @TranscriptDaily
Spark Therapeutics, Inc. $ONCE Upgraded at ValuEngine https://t.co/q1g4suIQJX
July 19th 2017, 11:07pm
intercooleronli @intercooleronli
Spark Therapeutics, Inc. $ONCE Upgraded to “Hold” at ValuEngine https://t.co/fatRjB2n0i
July 19th 2017, 11:07pm
RatingsNetwork @RatingsNetwork
Spark Therapeutics upgraded by ValuEngine to hold. https://t.co/ac8CxBz5GD $ONCE #ONCE
July 19th 2017, 11:07pm
SPNewsAnalysis @SPNewsAnalysis
Spark Therapeutics $ONCE versus Sucampo Pharmaceuticals $SCMP Financial Survey https://t.co/HBTg8Zrsmk
July 19th 2017, 2:07pm
storminvestor @storminvestor
Spark Therapeutics $ONCE versus Sucampo Pharmaceuticals $SCMP Financial Survey https://t.co/Ugt9dY2Ukb
July 19th 2017, 2:07pm
judyfr262 @judyfr262
@judyfr262 $ONCE heading back to 65 trend line resistance, someday will break thru
July 19th 2017, 1:07pm
TheMarketsDaily @TheMarketsDaily
Spark Therapeutics, Inc. $ONCE Upgraded to “Hold” at Zacks Investment Research https://t.co/2KF1Za8T72
July 19th 2017, 10:07am
TheMarketsDaily @TheMarketsDaily
Spark Therapeutics, Inc. $ONCE PT Set at $94.00 by Cantor Fitzgerald https://t.co/3bfE3FGsqM
July 19th 2017, 7:07am
midetimes @midetimes
Spark Therapeutics, Inc. $ONCE Upgraded to “Hold” at Zacks Investment Research https://t.co/6wPD4bgygy
July 19th 2017, 5:07am
dailypoliticaln @dailypoliticaln
Spark Therapeutics, Inc. $ONCE Upgraded to “Hold” at Zacks Investment Research https://t.co/NMusa39PZN
July 19th 2017, 5:07am
midetimes @midetimes
Spark Therapeutics, Inc. $ONCE PT Set at $94.00 by Cantor Fitzgerald https://t.co/YbsaFl7smb
July 19th 2017, 2:07am
dailypoliticaln @dailypoliticaln
Spark Therapeutics, Inc. $ONCE PT Set at $94.00 by Cantor Fitzgerald https://t.co/B74eD3jq5i
July 19th 2017, 2:07am
SPNewsAnalysis @SPNewsAnalysis
Spark Therapeutics, Inc. $ONCE Given a $94.00 Price Target at Cantor Fitzgerald https://t.co/bmnyc1lRsx
July 19th 2017, 12:07am
storminvestor @storminvestor
Spark Therapeutics, Inc. $ONCE Given a $94.00 Price Target at Cantor Fitzgerald https://t.co/QyUNShDIzB
July 19th 2017, 12:07am
ZolmaxNews @ZolmaxNews
Spark Therapeutics, Inc. $ONCE Given a $94.00 Price Target at Cantor Fitzgerald https://t.co/EUwckeLwZY
July 19th 2017, 12:07am
WatchlistN @WatchlistN
Spark Therapeutics $ONCE Earning Somewhat Positive News Coverage, Report Shows https://t.co/PdTZclzCAv
July 18th 2017, 8:07pm
fda_tracker @fda_tracker
$ONCE New PDUFA Date 2018-01-12 Spark Therapeutics, Inc. Link:https://t.co/th2DLxT5bd Calendar:https://t.co/sCt1qKoMdr
July 18th 2017, 9:07am
ChrisMLindgren @ChrisMLindgren
$ONCE
July 17th 2017, 11:07pm
YoungChris27040 @YoungChris27040
RT @JohnCendpts: FDA embraces the first US application for a gene therapy, offering an accelerated test case $ONCE https://t.co/BQdt5LBaHP
July 17th 2017, 8:07pm
TheBiotechBeat @TheBiotechBeat
RT @JohnCendpts: Trending -- FDA embraces the first US application for a gene therapy, offering an accelerated test case $ONCE https://t.co…
July 17th 2017, 6:07pm
Robert_P_Little @Robert_P_Little
$once Broker upgrades, good news today. I smell an issue coming.
July 17th 2017, 6:07pm
TickerReport @TickerReport
Spark Therapeutics, Inc. $ONCE Downgraded by Zacks Investment Research https://t.co/Tpp9W7ZrCh
July 17th 2017, 6:07pm
TickerReport @TickerReport
Spark Therapeutics, Inc. $ONCE Downgraded by Zacks Investment Research https://t.co/0NNvh7wWfV
July 17th 2017, 6:07pm
bankerstribune @bankerstribune
Cantor Fitzgerald reiterated Spark Therapeutics $ONCE at Buy. Fundamentals support Stocks rating… https://t.co/GWVEeZXlYv
July 17th 2017, 6:07pm
dailymailtimes @dailymailtimes
Spark Therapeutics, Inc. $ONCE Downgraded by Zacks Investment Research https://t.co/MeUe91P3Az
July 17th 2017, 6:07pm
emq_news @emq_news
Spark Therapeutics, Inc. $ONCE Downgraded by Zacks Investment Research https://t.co/zn0qhDdIXf
July 17th 2017, 6:07pm
BioPharmaDive @BioPharmaDive
$ONCE's approval application for its gene therapy for blindness has been accepted by the FDA https://t.co/A4XkiJBZzW
July 17th 2017, 6:07pm
midetimes @midetimes
Brokerages Anticipate Spark Therapeutics, Inc. $ONCE Will Announce Earnings of -$1.75 Per Share https://t.co/seknzbY751
July 17th 2017, 2:07pm
intercooleronli @intercooleronli
Brokerages Anticipate Spark Therapeutics, Inc. $ONCE Will Announce Earnings of -$1.75 Per Share https://t.co/FJqpzicz7o
July 17th 2017, 2:07pm
dailypoliticaln @dailypoliticaln
Brokerages Anticipate Spark Therapeutics, Inc. $ONCE Will Announce Earnings of -$1.75 Per Share https://t.co/TbjINzwQfr
July 17th 2017, 2:07pm
JohnCendpts @JohnCendpts
Trending -- FDA embraces the first US application for a gene therapy, offering an accelerated test case $ONCE https://t.co/BQdt5LBaHP
July 17th 2017, 2:07pm
dakotafinancial @dakotafinancial
Spark Therapeutics, Inc. $ONCE Rating Reiterated by Cantor Fitzgerald https://t.co/cJP3sQHJjo
July 17th 2017, 12:07pm
realJacobBell @realJacobBell
First gene therapy could hit the market in January https://t.co/ESZP5TFVzG $ONCE
July 17th 2017, 12:07pm
BioPharmaDive @BioPharmaDive
First gene therapy could hit the market in January https://t.co/A4XkiJBZzW $ONCE
July 17th 2017, 12:07pm
RatingsNetwork @RatingsNetwork
Spark Therapeutics's buy rating reiterated at Cantor Fitzgerald. https://t.co/ty8E4IMrDG $ONCE #ONCE
July 17th 2017, 11:07am
tickerws @tickerws
FDA accepts $ONCE marketing application for gene therapy for retinal disease, action date January 12; shares +2.90%
July 17th 2017, 10:07am
SEEKINGALPHA_FS @SEEKINGALPHA_FS
FDA accepts Spark's marketing application for gene therapy for retinal disease, action date January 12; sha... https://t.co/n0WAAr4pgd $ONCE
July 17th 2017, 10:07am
MarketCurrents @MarketCurrents
FDA accepts Spark's marketing application for gene therapy for retinal disease, action date January 12; sha... https://t.co/ls6JhGMVfk $ONCE
July 17th 2017, 10:07am
kjilly @kjilly
#FDA embraces the first US application for a #genetherapy, offering an accelerated test case #biotech $ONCE @endpts https://t.co/0PGIyFofMz
July 17th 2017, 10:07am
Faisalk_Can @Faisalk_Can
starting position in $ONCE before new highs!
July 17th 2017, 9:07am
JohnCendpts @JohnCendpts
FDA embraces the first US application for a gene therapy, offering an accelerated test case $ONCE https://t.co/BQdt5LBaHP
July 17th 2017, 9:07am
jfais20 @jfais20
$ONCE my prior piece https://t.co/k8XDy5UBmz
July 17th 2017, 8:07am
YuZhu4 @YuZhu4
RT @bradloncar: The $ONCE gene therapy PDUFA is the Friday of #JPM18 week.
July 17th 2017, 8:07am
tickerws @tickerws
$ONCE: FDA accepts BLA, grants Priority Review to Voretigene Neparvovec https://t.co/c71TjI6E6C
July 17th 2017, 8:07am
ProTradersNews @ProTradersNews
$ONCE: Spark Therapeutics’ Biologics License Application for Investigational …: https://t.co/FMKVdl5Mz5
July 17th 2017, 7:07am

Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.